Cat
2,904 reported events
openFDA
Top reactions: Lethargy (see also Central nervous system depression in Neurological) (486) · Vomiting (382) · Application site hair loss (275) · Hypersalivation (270) · Foaming at the mouth (243)
Canada — Health Canada DPD
NEXGARD COMBO
Authorised animal medicine, recorded in Canada — Health Canada DPD. This is a neutral reference record and does not provide dosing or veterinary advice.
Reference information only — not veterinary advice and not a dosing source. Always consult a licensed veterinarian before giving any medicine to an animal.
Active substances
Target species
cats
Authorisation
No. 02511231
Source
Canada — Health Canada DPD. Original source.
Other Esafoxolaner medicines
- NEXGARD COMBO SOLUCION SPOT-ON PARA GATOS 2,5 - 7,5 kg · 2 pack sizes
- NEXGARD COMBO SOLUCION SPOT-ON PARA GATOS < 2,5 kg · 2 pack sizes
- NEXGARD COMBO SOLUTION POUR SPOT-ON POUR CHATS 2,5 - 7,5 KG
- NEXGARD COMBO SOLUTION POUR SPOT-ON POUR CHATS < 2,5 KG
- NexGard Combo Spot-on Solution for Cats 2.5-7.5 kg · 2 pack sizes
- NexGard Combo Spot-on Solution for Cats <2.5 kg · 2 pack sizes
- NexGard® COMBO
- Nexgard Spectra Spot-On for Cats 0.8 - 2.4 kg
Reported adverse events (openFDA)
Spontaneous adverse-event reports that name Esafoxolaner, by species — reported counts, not proven reactions.
Source: openFDA Animal & Veterinary adverse-event reports.
Surveillance reference only — these are spontaneous adverse-event report counts, not proven adverse reactions, not causation and not a measure of any product's risk or safety. Always consult a licensed veterinarian.